Case Reports in Neurological Medicine

Case Reports in Neurological Medicine / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 8371697 |

Constantine L. Karras, Isaac Josh Abecassis, Zachary A. Abecassis, Joseph G. Adel, Esther N. Bit-Ivan, Rakesh K. Chandra, Bernard R. Bendok, "Clival Ectopic Pituitary Adenoma Mimicking a Chordoma: Case Report and Review of the Literature", Case Reports in Neurological Medicine, vol. 2016, Article ID 8371697, 8 pages, 2016.

Clival Ectopic Pituitary Adenoma Mimicking a Chordoma: Case Report and Review of the Literature

Academic Editor: Mehmet Turgut
Received03 Nov 2015
Accepted14 Dec 2015
Published13 Jan 2016


Background. Purely ectopic pituitary adenomas are exceedingly rare. Here we report on a patient that presented with an incidental clival mass thought to be a chordoma. Endonasal resection, tumor pathology, and endocrinology workup revealed a prolactinoma. Case Presentation. A 41-year-old male presented with an incidental clival lesion presumed to be a chordoma. On MRI it involved the entire clivus, extended laterally to the petroclival junction, and invaded the cavernous sinuses bilaterally, encasing both internal carotid arteries, without direct extension into the sella. Intraoperatively, it was clear that the tumor originated from the clivus and that the sellar dura was completely intact. Frozen-section pathology was consistent with a pituitary adenoma. Immunostaining was positive for synaptophysin and prolactin with a low Ki-67 index, suggestive of a prolactinoma. Additional immunohistochemical stains seen in chordomas (EMA, S100, and Brachyury) and other metastatic tumors were negative. A postoperative endocrine workup revealed an elevated serum prolactin of 881.3 ng/mL (normal < 20). Conclusions. In conclusion, it is crucial to maintain an extensive differential diagnosis when evaluating a patient with a clival lesion. Ectopic clival pituitary adenomas, although rare, may warrant an endocrinological workup preoperatively as the majority may respond to medical treatment.

1. Introduction

Pituitary adenomas are the most common cause of a sellar or parasellar mass, comprising about 10 to 15 percent of all intracranial tumors [1, 2]. It is well documented that pituitary adenomas have the capacity to invade adjacent and nearby structures, most commonly the sphenoid sinus [3]. Less commonly, pituitary adenomas may also involve the cavernous sinus, suprasellar region, nasopharynx, and rarely the clivus [4]. Purely ectopic pituitary adenomas are extremely unusual and must be confirmed via imaging and intraoperative visualization to be completely separate from an intact pituitary gland and the sella turcica. Here we report on a patient that presented with an incidental clival mass thought to be a chordoma. Endonasal resection, pathology of the tumor, and endocrinology workup revealed a purely ectopic prolactin-secreting pituitary adenoma.

2. Case Report

Our patient was a 41-year-old right-handed male who presented with an incidental clival lesion, originally presumed to be a chordoma. Subjectively, the patient reported no neurological complaints. The patient’s medical history was significant only for chronic neck and lower back pain and there were no noteworthy findings on physical examination, which included a thorough neurological exam. His complete blood count, chemistry panel, and metabolic panel were all normal.

Repeat magnetic resonance imaging (MRI) revealed an enhancing lesion measuring 1.7 × 2.6 × 3.2 cm that involved the entire clivus, extended laterally to the petroclival junction, and invaded the cavernous sinuses bilaterally with further encasement of the internal carotid arteries (ICAs) bilaterally, without direct extension into the sella (Figures 1(a)-1(b) and 2(a)2(c)). This lesion was stable in comparison to outside hospital images. The case was discussed at an interdisciplinary brain tumor meeting and, ultimately, the patient was advised to undergo surgical resection via an endoscopic endonasal approach. Intraoperatively, it was very clear that the tumor originated from the clivus and that the sellar dura was completely intact. The frozen-section pathology surprisingly was consistent with a pituitary adenoma. Accordingly, a decision was made perioperatively to proceed with only partial resection due to the potential for medical management of most functional adenomas postoperatively and the risks associated with complete resection given the complex distribution of the lesion. The patient had no complications and was discharged home on postoperative day 2.

Postoperative imaging revealed expected residual enhancing lesions along the petroclival junctions bilaterally and on the right cavernous sinus near the right ICA (Figures 3(a) and 3(b)). Immunostaining of the tumor tissue demonstrated an epithelial neoplasm that stained positive for synaptophysin and prolactin with a low Ki-67 index (Figures 4(a)4(d)), suggestive of a prolactin-secreting pituitary adenoma. Additional immunohistochemical stains seen in chordomas (EMA, S100, and Brachyury) and other metastatic tumors were negative. A postoperative endocrine workup (Table 1) revealed an elevated serum prolactin of 881.3 ng/mL (normal male < 20 ng/mL). The patient was referred to an endocrinologist and began dopamine agonist (cabergoline) therapy given his prolactin level and residual tumor. He has since been followed up for over 1 year with monthly visits. His most recent prolactin level (11 months postoperatively) was 20.6 ng/mL; his lowest level was 15.2 ng/mL, collected 6 months postoperatively. He remains neurologically intact.

PatientReference range

Free T4 (ng/dL)0.70.7–1.5
TSH (μIU/mL)2.580.4–4.0
Prolactin (ng/mL)881.32.6–13.1
FSH (mlU/mL)31.0–8.0 (Men)
LH (mlU/mL)3.12.0–12.0 (Men)
Cortisol, 2PM (μg/dL)6.80–25
Total testosterone (ng/dL)290250–1100
Free testosterone (pg/mL)58.435–155

T4 = thyroxine hormone.
TSH = thyroid stimulating hormone.
FSH = follicle stimulating hormone.
LH = luteinizing hormone.

3. Discussion

Clival tumors are generally rare, comprising 1% of all intracranial neoplasms. The differential diagnosis for a clival lesion is vast, including chordoma most commonly (40%), meningioma, chondrosarcoma, astrocytoma, craniopharyngioma, germ cell tumor, non-Hodgkin’s lymphoma, melanoma, metastatic carcinoma, and rarely pituitary adenoma [4]. Our patient was presumed to have a chordoma based on the radiographic characteristics and the tumor location. Clival chordomas are typically managed with gross total resection with proton beam therapy. There has been one previous report of an ectopic pituitary adenoma thought to be a chordoma [12] and vice versa [4].

Ectopic pituitary adenomas are thought to arise from residual cells along the migration tract of the pharyngeal pituitary as it travels from Rathke’s pouch to the sella turcica. The anterior portion of the pituitary initially develops as a pharyngeal outpouching of epithelial ectoderm, known as Rathke’s pouch. Around week 8 of gestation, a portion separates and migrates through the craniopharyngeal canal into the sella, forming the anterior portion of the pituitary, from which most pituitary adenomas arise [9, 16]. Ectopically deposited cells can rarely develop into adenomas anywhere along this tract, though. There have been over 100 descriptions of ectopic pituitary adenomas in the literature, most originating in the sphenoid sinus [17]. The first reported, in 1901, was an ectopic pituitary adenoma [10] located in the sphenoid sinus that presented with acromegaly. However, purely ectopic clival pituitary adenomas—that is, tumors that originate in the clivus with no involvement of the pituitary gland—are exceedingly rare.

We encountered 16 prior reported cases of clival ectopic pituitary adenomas (Table 2) [49, 1114, 1721]. They seem to be fairly equally distributed between genders (9 males, 8 females) and the median age at presentation was 50 years old.


AuthorsPatient age and genderImmunostainingInitial presentation

Ortiz-Suarez and Erickson, 1975 [11]15 FACTHObesity, irregular menstrual cycles, increased facial hair, episodic headaches, and facial numbness
Shenker et al., 1986 [21]49 MProlactinWorsening renal failure, hypercalcemia, duodenal ulcer, parathyroid hyperplasia, fatigue, muscle pains, vomiting, and impotence
Anand et al., 1993 [18]58 FACTHNasal obstruction, blurred vision, anosmia, and headache
Mount et al., 1993 [20]71 MProlactinAphasia and R hemiplegia
Arnesen and Scheithauer, 1994 [7]40 MProlactinBloody, mucoid nasal discharge, and nasal obstruction
Kikuchi et al., 1994 [12]49 FNull cellHeadaches, nausea, and vomiting after neck injury; incidentally discovered
Wong et al., 1995 [4]67 MNull cellUnknown
De Witte et al., 1998 [19]47 FProlactinHeadache
Hori et al., 1999 [17]63 MNull cellVisual disturbances
Ballaux et al., 1999 [14]80 FProlactinMinor headache and transient amnesia
Sakakibara et al., 2002 [6]70 FProlactinProgressive L sided exophthalmos
Bhatoe et al., 2007 [5]35 FGHDull generalized headache, acral enlargement, weight gain, and coarsening facial features
Rocque et al., 2009 [9]20 MProlactinBilateral gynecomastia and galactorrhea
Appel et al., 2012 [8]50 FGH/prolactinDaily headaches, impaired concentration, fatigue, generalized muscle/joint pain, and acromegalic facial features
Mudd et al., 2012 [14]78 MNull cellAcute onset blurred vision, apoplexy
Narese et al., 2015 [4]65 MProlactinRight ptosis, eyelid edema, and headache
This paper41 MProlactinIncidental imaging due to chronic neck and lower back pain


Focal neurological findingsImagingAbnormal preoperative labs (ng/mL)TreatmentFollow-up; outcomes

Oculomotor and trigeminal nerve palsiesSkull XR: mottling, sclerosis of sella turcica, and lesser wing of sphenoid. CT: normal.
Carotid angiogram: medial displacement of ICA
NoneRight transfrontal craniotomy + 5000 Rads 1 year; returned to baseline

NoneSkull XR: enlarged sella, CT: partially empty sella, destroyed sella floor, and mass at base of sella with invasion into sphenoid sinusPRL = 1900Endonasal transsphenoidal resection + cabergoline1 year; no recurrence, impotence resolved

L eye inferior medial quadrant visual field defect MRI: 3 × 3 cm, midline homogenous mass filling posterior nasopharynx and clivusNoneTotal resection via open-door maxillotomy approach + 4550 Rads over 25 1 year; complete resolution of symptoms

UnknownCT/MRI: L frontotemporal hematoma, meningioma, expansile density with invasion into sphenoid bone and clivus, and encasing ICAsNoneEndonasal transsphenoidal biopsy only + radiationNo improvement, transferred to receive supportive care

UnknownMRI: tumor eroding through skull base into the clivus extending into sphenoid sinus, cavernous sinus, and surrounding ICAUnknownPartial endonasal transsphenoidal resectionUnknown

NoneSkull XR: normal size sella, slight erosion of floor CT/MRI: large enhancing mass in sphenoid sinus invading sphenoid wing and clivusNonePartial resection via sublabial transnasal approach + 50 Gy radiation/6 wksUnclear; “under careful observation”

UnknownMRI: clival destructionPRL = 7UnknownUnknown

NoneCT/MRI: clival lesion, destruction of boneNone (Post-op PRL = 34,000)Endonasal transsphenoidal partial resection + bromocriptine4 months; normalization of lab values

Bitemporal hemianopsiaCT: lesion in extradural sella-clivus regionUnknownTransfacial surgeryUnknown

NoneCT: tumor at clivus with surrounding bony destruction. MRI: enhancing mass with cystic component, invading sphenoid sinusPRL = 2519.8Cabergoline only6 months; resolution of lab values and symptoms

Exophthalmos with external ocular movement disorders and decreased visual acuity on LCT: bony destruction of clivus, sphenoid sinus, and medial aspect of middle cranial fossa, MRI: abnormal enhancement in sphenoid sinusPRL = 645.7Endonasal transsphenoidal resection + Bromocriptine therapy1 year f/u; resolution of visual symptoms

UnknownSkull radiograph: normal, MRI: clival mass connected to intrasellar lesionGH = 30.6Endonasal transsphenoidal resection1 year; normalization of lab values

NoneMRI: 13 mm erosive mass in clivus with focal area of bony erosionPRL = 178Endonasal transsphenoidal total resection6 months; complete resolution of symptoms

NoneMRI: 2 mm hypointense lesion on pituitary gland. Clival lesion discovered incidentally during surgeryIGF-1 = 937, PRL = 26Endoscopic transsphenoidal; clival mass encountered and resected, pituitary unremarkable3 months; normalization of lab values, no report on clinical status

L CN 6 palsyMRI: lytic lesion of left clivus, compression of cavernous sinuses, clival mass, and normal sellaNoneEndoscopic transsphenoidal resection2.5 years; resolution of CN6 palsy and no recurrence

NoneMRI: large tumor at height of clivus, partial destruction of surrounding bone structureUnknownEndoscopic transsphenoidal resectionUnknown

NoneMRI: enhancing lesion in clivus with extension into cavernous sinuses and encasement of the ICAsPRL = 881.3 Endoscopic transsphenoidal; subtotal resection and dopamine antagonist1 year; no symptoms

F = female.
M = male.
GH = growth hormone.
PRL = prolactin.
ACTH = adrenocorticotropic hormone.
IGF-1 = insulin-like growth factor-1.
MRI = magnetic resonance imaging.
CT = computed tomography.
XR = X-ray.
ICAs = internal carotid arteries.
L = left.
CN = cranial nerve.

Like pituitary adenomas, ectopic tissue can be categorized by size as either a macroadenoma (>1 cm) or microadenoma (<1 cm). The tumor can be further classified as functional (65% of nonectopic adenomas) or nonfunctional based on whether or not the cell type is hormone-secreting. Prolactin-secreting pituitary adenomas (nonectopic) are the most common and comprise 48% of all functional adenomas [22]. Occasionally, pituitary adenomas can lack the cardinal features found on light microscopy and immunohistochemical staining that were present in our case. Electron microscopy of these tumors may aid in further classification of the cell type based on appearance of the nucleus, cytoplasm, organelles (including rough endoplasmic reticulum and Golgi apparatus), and granule morphology [7].

Analysis of Table 2 reveals that 10/17 clival ectopic pituitary tumors described were prolactinomas, 2/17 secreted ACTH, 2/17 secreted GH, and only 4/17 were nonfunctional—one tumor secreted both prolactin and GH [8]. Some (especially nonfunctional tumors) presented asymptomatically or with focal neurological deficits (5/17 cases) due to compression of nearby structures. The most common theme among patient presentations in the literature review was “frequent headache” in the period leading up to diagnosis. Pituitary adenomas often classically present with bitemporal hemianopsia, but ectopic adenomas typically do not unless they happen to involve the optic chiasm. One case presented as pituitary apoplexy—tumor infarction or hemorrhage resulting in a constellation of symptoms that may include headache, visual deficits, ophthalmoplegia, or altered mental status [13]. Most of these findings are nonspecific, however, and cannot distinguish a pituitary adenoma from other lesions such as a chordoma.

Fortunately, a surprising 76% (13/17) of reported cases were functional adenomas, permitting a possible preoperative diagnosis based on history, physical exam, and basic labs alone. ACTH-secreting adenomas may present with Cushing’s syndrome (moon facies, truncal obesity, abdominal striae, hirsutism, etc.), characterized by hypercortisolism and an abnormal dexamethasone suppression test. GH-secreting adenomas may manifest as acromegaly in adults, which presents with enlargement of the extremities, coarse facies (frontal bossing, prognathism), carpal tunnel syndrome, diabetes, or cardiomyopathy—labs would reveal elevated IGF-1 (insulin-like growth factor) and a failed oral glucose tolerance test. Prolactinomas, which comprised the majority of cases (10/17), may present with gynecomastia, erectile dysfunction, decreased libido, galactorrhea, amenorrhea (in females), and an elevated prolactin level. Of note, after a more focused history following our postoperative diagnosis of prolactinoma, it was discovered retrospectively that our patient had actually had a significant drop in libido throughout the previous 7-8 years.

Our case was unique in that it was the first reported clival ectopic pituitary adenoma that invaded both cavernous sinuses and the internal carotid arteries, making it the most aggressive tumor of all reported cases—this is unusual for adenomas, as they typically are quite less infiltrative. This is why it was originally confused for a chordoma, but it is particularly important to maintain pituitary adenomas on the differential for sphenoidal or clival lesions because the diagnosis can have significant implications on the management of the tumor. For example, dopamine agonists (cabergoline, bromocriptine) and somatostatin analogs (octreotide, lanreotide) or GH antagonists (pegvisomant) are first-line therapy for prolactinomas and GH-secreting adenomas, respectively, depending on the clinical symptoms and anatomical distribution of the tumor. They may be used as monotherapy or as adjunctive treatment for tumor shrinkage. With 76% (13/17) of reported clival ectopic adenomas being hormone-secreting and 85% (11/13) of these being susceptible to medical management (GH- or prolactin-secreting), a significant opportunity exists for more conservative management if the diagnosis can be made preoperatively rather than retrospectively based on histology. This is especially useful for more aggressive tumors (such as our patient’s, which invaded the cavernous sinus), where a complete resection may carry significant risk of bleeding and morbidity. Adjunctive pharmacotherapy can also potentially delay or even eliminate the need for surgery, especially in elderly individuals or in those with significant medical comorbidities and relative contraindications to surgery.

A common theme among reported cases, including ours, was that the correct diagnosis was made histologically rather than preoperatively. Management could have been drastically altered in most of these cases had a more focused, thorough history and physical exam alone occurred.

4. Conclusions

In conclusion, it is important to maintain an extensive differential diagnosis when evaluating a patient with a clival lesion. Ectopic clival pituitary adenomas, although rare, warrant consideration as the majority respond to pharmacotherapy [14] and thus are managed much differently than lesions such as chordomas. The diagnosis can easily be screened for with a focused history and physical exam directed toward symptoms of the most common types (prolactin-, GH-, and ACTH-secreting adenomas), which make up the majority (76%) of reported clival ectopic adenomas. If the history and physical exam yield a positive screen, a preoperative endocrinological workup is necessary to confirm the diagnosis.

Conflict of Interests

The authors declare that they have no conflict of interests.


  1. P. J. Pernicone and B. W. Scheithauer, “Invasive pituitary adenomas and pituitary carcinomas,” in Surgical Pathology of the Pituitary Gland, R. V. Lloyd, Ed., pp. 121–136, WB Saunders, Philadelphia, Pa, USA, 1993. View at: Google Scholar
  2. T. Terada, K. Kovacs, L. Stefaneanu, and E. Horvath, “Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases,” Endocrine Pathology, vol. 6, no. 4, pp. 301–310, 1995. View at: Publisher Site | Google Scholar
  3. F. Tovi, M. Hirsch, M. Sacks, and A. Leiberman, “Ectopic pituitary adenoma of the sphenoid sinus: report of a case and review of the literature,” Head and Neck, vol. 12, no. 3, pp. 264–268, 1990. View at: Google Scholar
  4. K. Wong, J. Raisanen, S. L. Taylor, M. W. McDermott, C. B. Wilson, and P. H. Gutin, “Pituitary adenoma as an unsuspected clival tumor,” The American Journal of Surgical Pathology, vol. 19, no. 8, pp. 900–903, 1995. View at: Publisher Site | Google Scholar
  5. H. S. Bhatoe, N. Kotwal, and S. Badwal, “Clival pituitary adenoma with acromegaly: case report and review of literature,” Skull Base, vol. 17, no. 4, pp. 265–268, 2007. View at: Publisher Site | Google Scholar
  6. Y. Sakakibara, H. Sekino, Y. Taguchi, and M. Tadokoro, “Unilateral exophthalmos caused by a prolactin producing ectopic pituitary adenoma: case report,” Neurological Surgery, vol. 30, no. 6, pp. 623–628, 2002. View at: Google Scholar
  7. M. Arnesen and B. W. Scheithauer, “Aggressive small cell tumor of the skull base,” Ultrastructural Pathology, vol. 18, no. 1-2, pp. 191–197, 1994. View at: Publisher Site | Google Scholar
  8. J. G. Appel, M. Bergsneider, H. Vinters, N. Salamon, M. B. Wang, and A. P. Heaney, “Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature,” Pituitary, vol. 15, supplement 1, pp. S53–S56, 2012. View at: Publisher Site | Google Scholar
  9. B. G. Rocque, K. A. G. Herold, M. S. Salamat, Y. Shenker, and J. S. Kuo, “Symptomatic hyperprolactinemia from an ectopic pituitary adenoma located in the clivus,” Endocrine Practice, vol. 15, no. 2, pp. 143–148, 2009. View at: Publisher Site | Google Scholar
  10. J. Erdheim, “Über einen hypophysentumor von ungewöhnlichem,” Beiträge zur Pathologischen Anatomie und zur Allgemeinen Pathologie, vol. 46, pp. 233–240, 1909. View at: Google Scholar
  11. H. Ortiz-Suarez and D. L. Erickson, “Pituitary adenomas of adolescents,” Journal of Neurosurgery, vol. 43, no. 4, pp. 437–439, 1975. View at: Publisher Site | Google Scholar
  12. K. Kikuchi, M. Kowada, J. Sasaki, and M. Sageshima, “Large pituitary adenoma of the sphenoid sinus and the nasopharynx: report of a case with ultrastructural evaluations,” Surgical Neurology, vol. 42, no. 4, pp. 330–334, 1994. View at: Publisher Site | Google Scholar
  13. P. A. Mudd, S. Hohensee, K. O. Lillehei, T. T. Kingdom, and B. K. Kleinschmidt-DeMasters, “Ectopic pituitary adenoma of the clivus presenting with apoplexy: case report and review of the literature,” Clinical Neuropathology, vol. 31, no. 1, pp. 24–30, 2012. View at: Publisher Site | Google Scholar
  14. D. Ballaux, J. Verhelst, B. Pickut, P. P. De Deyn, and C. Mahler, “Ectopic macroprolactinoma mimicking a chordoma: a case report,” Endocrine-Related Cancer, vol. 6, no. 1, pp. 117–122, 1999. View at: Publisher Site | Google Scholar
  15. D. Narese, V. Virzì, G. Virzì et al., “Ectopic prolactinoma in the clivus: a case report,” La Clinica Terapeutica, vol. 166, no. 4, pp. 176–178, 2015. View at: Publisher Site | Google Scholar
  16. W. J. Hamilton, J. D. Boyd, and H. W. Mossman, “Prenatal development of form and function,” in Human Embryology, Heffer and Sons Ltd, pp. 345–346, Cambridge, UK, 1945. View at: Google Scholar
  17. A. Hori, D. Schmidt, and E. Rickels, “Pharyngeal pituitary: development, malformation, and tumorigenesis,” Acta Neuropathologica, vol. 98, no. 3, pp. 262–272, 1999. View at: Publisher Site | Google Scholar
  18. V. K. Anand, C. M. Osborne, and H. L. Harkey III, “Infiltrative clival pituitary adenoma of ectopic origin,” Otolaryngology—Head and Neck Surgery, vol. 108, no. 2, pp. 178–183, 1993. View at: Publisher Site | Google Scholar
  19. O. De Witte, N. Massager, I. Salmon, S. Meyer, G. Dooms, and J. Brotchi, “Ectopic prolactinoma in the clivus,” Acta Chirurgica Belgica, vol. 98, no. 1, pp. 10–13, 1998. View at: Google Scholar
  20. S. L. Mount, D. J. Taatjes, and T. D. Trainer, “Ultrastructural study of a pituitary adenoma (prolactinoma) within the clivus bone using immunoelectron microscopy,” Ultrastructural Pathology, vol. 17, no. 6, pp. 637–642, 1993. View at: Publisher Site | Google Scholar
  21. Y. Shenker, R. V. Lloyd, L. Weatherbee, F. K. Port, R. J. Grekin, and A. L. Barkan, “Ectopic prolactinoma in a patient with hyperparathyroidism and abnormal sellar radiography,” Journal of Clinical Endocrinology and Metabolism, vol. 62, no. 5, pp. 1065–1069, 1986. View at: Publisher Site | Google Scholar
  22. B. M. Biller, B. Swearingen, N. T. Zervas, and A. Klibanski, “A decade of the massachusetts general hospital neuroendocrine clinical center,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 6, pp. 1668–1674, 1997. View at: Publisher Site | Google Scholar

Copyright © 2016 Constantine L. Karras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.